We all know someone affected by the battle against cancer. And we know that treatments can be quite efficient at shrinking the tumor but too often, they can’t kill all the cells, and so it may come back. With some aggressive types of cancer, the problem is so great that there is very little that can be done for the patients.
Why do some cancer cells evade therapy?
To understand this problem, we need to “look” at the molecular machinery inside the cancer cells that regulates their ability to grow, stay alive, and divide, producing more cells.
Scientists have identified many mechanisms within this machinery and they have designed drugs and other treatments that interfere with them, blocking their ability to divide, or even killing them.
Clearly, these treatments are not able to kill all the cells within a tumor. This must mean that some cancer cells can use alternative mechanisms which are not affected by current treatments. In this way, they evade therapy and regenerate the tumor, leading to recurrence.
The lab of Andreas Androutsellis-Theotokis at the Department of Internal Medicine III (MK3) at the Technische Universität Dresden, in Germany had previously discovered a new molecular mechanism that regulates regeneration of various tissues after injury. They named it “The STAT3-Ser/Hes3 Signaling Axis”, after two of its key components and they demonstrated that it is very important in activating stem cells that live within our tissues so that they may help the tissue regenerate in models of Parkinson’s disease, ischemic stroke, multiple sclerosis, and types 1 and 2 diabetes. They posited that the same mechanism could be hijacked by some cancer cells (perhaps the elusive cancer stem cells) as a means of evading current therapies and regenerating the tumor.
Research Fellow Steve Poser and colleagues set to test the idea using cells from multiple patients with aggressive brain cancer. They demonstrated that, indeed, these cells can switch over from using the more established molecular mechanisms to using this new mechanism. Depending on which mechanism they were using, they were vulnerable to different treatments.
The team established an international and interdisciplinary collaborative project to characterize this new cancer cell state in terms of what genes are turned on and off, what mechanical properties are affected (these are important in metastasis because they regulate how cells move and spread within the tissue), and to find treatments that kill the cells specifically when this new molecular mechanism is in use.
In this way, they could block this escape route of the cancer cells. The findings are published in the Journal of the Federation of American Societies for Experimental Biology (FASEB J; https://www.fasebj.org/doi/10.1096/fj.201802603RR).
They identified several treatments that kill the cancer cells when they operate this new mechanism. In fact, several treatments are so specific that they kill the cells only when they operate the new mechanism and have minimal effects when they operate the more established, classical cancer growth mechanisms. Many of the treatments are currently approved for use in different indications (not cancer) and so they could potentially be repurposed in oncology.
Other treatments, such as the direct targeting of the gene Hes3 by RNA interference methods, would be new to man. To expedite the possibility to bring these new potential therapies to the clinic, the Technische Universität Dresden, with the support of the transCampus Initiative (a formal collaboration between the Technische Universität Dresden, in Germany and King’s College, London, UK) and the transCellerator, has formed a spinoff venture, Innate Repair.
Whereas the initial focus is on aggressive brain cancer, there already is ample evidence that the same mechanism operates in many additional types of cancer. The work provides a new logic and method to identify treatments that kill these hard-to-kill cancer cells.
PD Dr. Andreas Androutsellis-Theotokis, PhD
Technische Universität Dresden
University Hospital Carl Gustav Carus Dresden
Department of Internal Medicine III (MK3)
Tel.: +49 351 458 3207
„Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery“, Journal of the Federation of American Societies for Experimental Biology (FASEB J; https://www.fasebj.org/doi/10.1096/fj.201802603RR)
Kim-Astrid Magister | idw - Informationsdienst Wissenschaft
If Machines Could Smell ...
19.07.2019 | Fraunhofer-Institut für Produktionstechnik und Automatisierung IPA
Algae-killing viruses spur nutrient recycling in oceans
18.07.2019 | Rutgers University
Adjusting the thermal conductivity of materials is one of the challenges nanoscience is currently facing. Together with colleagues from the Netherlands and Spain, researchers from the University of Basel have shown that the atomic vibrations that determine heat generation in nanowires can be controlled through the arrangement of atoms alone. The scientists will publish the results shortly in the journal Nano Letters.
In the electronics and computer industry, components are becoming ever smaller and more powerful. However, there are problems with the heat generation. It is...
Scientists have visualised the electronic structure in a microelectronic device for the first time, opening up opportunities for finely-tuned high performance electronic devices.
Physicists from the University of Warwick and the University of Washington have developed a technique to measure the energy and momentum of electrons in...
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.
Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...
For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.
Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...
An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".
The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...
24.06.2019 | Event News
29.04.2019 | Event News
17.04.2019 | Event News
19.07.2019 | Physics and Astronomy
19.07.2019 | Physics and Astronomy
19.07.2019 | Earth Sciences